You’ve reached your weight loss goal on GLP-1 medications – what now?

Photo credit: SHVETS production via Pexels. Article by Amy J. Sheer. The Conversation – February 5, 2026.

GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone from niche diabetes treatments to household names, reshaping how America thinks about weight loss. A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one of these drugs, Wegovy, has become available in pill form, increasing its accessibility for many people. […]

Click here to view original web page at www.theconversation.com